MAUDE Adverse Event Report: INSTITUT STRAUMANN AG RIDGEFIT, Ø2.4, GH2.8, SLA®, 14,TIN, RXD; ENDOSSEOUS DENTAL IMPLANT

Catalog Number	042.949S
Medical Device Problem Code	Failure to Osseointegrate (1863)
Health Effect - Clinical Codes	Unspecified Infection (1930); Fibrosis (3167)
Date of Event	02/02/2024
Type of Reportable Event	Serious Injury
Event or Problem Description
The clinician reports the implant was inserted (b)(6) 2023 in ada 23.Details of surgery: implant surface not completely covered with bone.On (b)(6) 2024, non-osseointegration was verified.The device was forwarded to the manufacturer.At the event the patient experienced: peri-implantitis and mobility.No further patient complications were reported.

• Brand Name: RIDGEFIT, Ø2.4, GH2.8, SLA®, 14,TIN, RXD
• Common Device Name: ENDOSSEOUS DENTAL IMPLANT
• Manufacturer (Section D): INSTITUT STRAUMANN AG; peter merian-weg 12; basel 04002 ; SZ 04002
• MDR Report Key: 19107116
• Report Number: 0001222315-2024-000956
• Device Sequence Number: 12704269
• Product Code: DZE
• UDI-Device Identifier: 07630031753649
• UDI-Public: 07630031753649
• Combination Product (Y/N): N
• Initial Reporter State: CA
• Initial Reporter Country: US
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2023
• Device Explanted Year: 2024
• Serviced by Third Party (Y/N): N
• Reporter Type: Importer
• Initial Reporter Occupation: Dentist
• Type of Report: Initial
• Report Date (Section B): 04/15/2024
• Report Date (Section F): 03/20/2024

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Expiration Date: 08/31/2025
• Device Catalogue Number: 042.949S
• Device Lot Number: 20-424036
• Was Device Available for Evaluation?: Device Returned to Manufacturer
• Date Returned to Manufacturer: 03/20/2024
• Is the Reporter a Health Professional?: Yes
• Was the Report Sent to FDA?: No
• Distributor Facility Aware Date: 04/15/2024
• Device Age: 42 MO
• Event Location: Other
• Date Report to Manufacturer: 03/20/2024
• Initial Date Received by Manufacturer: Not provided
• Initial Report FDA Received Date: 04/15/2024
• Was Device Evaluated by Manufacturer? (Y/N): Yes
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 50 YR
• Patient Sex: Male